{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:23:17Z","timestamp":1794615797582,"version":"4.9.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Fixed drug eruption (FDE) is classically a lymphocyte-predominant interface dermatitis, but an early lesion may show a prominent neutrophilic infiltrate that closely simulates a primary neutrophilic dermatosis. We report 2 cases. The first, a 42-year-old woman, developed a multifocal eruption approximately 45 minutes after re-exposure to etoricoxib, recurring at previously affected and new sites. A punch biopsy performed 21 hours after ingestion of the drug showed a basketweave stratum corneum, intense papillary dermal edema with pseudovesiculation, and a superficial and deep infiltrate rich in neutrophils with karyorrhexis, closely resembling Sweet syndrome. Only occasional apoptotic keratinocytes were present within the epidermis, and the marked edema obscured any interface dermatitis, although admixed eosinophils were noted. Clinicopathologic correlation ultimately established the diagnosis of neutrophilic FDE. The second, a 55-year-old man, had an eruption recurring at the same sites after pseudoephedrine. A biopsy of an established lesion 2\u20133 weeks after ingestion showed classic interface dermatitis with numerous eosinophils and pigment incontinence, whereas one taken from the same region within 24 hours of re-exposure showed a neutrophil-predominant infiltrate with prominent karyorrhexis and only focal interface change. These cases, biopsied at documented time points, support the concept that the neutrophil-rich appearance of FDE represents an early phase in its histopathologic evolution, demonstrate how it can be mistaken for a neutrophilic dermatosis in the absence of adequate clinical history, and show that clinicopathologic correlation and a high index of suspicion are necessary to reliably arrive at the correct diagnosis.<\/jats:p>","DOI":"10.1097\/dad.0000000000003454","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:00:32Z","timestamp":1792072832000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophilic Fixed Drug Eruption Mimicking Neutrophilic Dermatosis: Two Cases, Including Sequential Biopsies Demonstrating Time-Dependent Histopathology"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8580-4615","authenticated-orcid":false,"given":"Padol","family":"Chamninawakul","sequence":"first","affiliation":[{"name":"National Skin Center, Singapore;"},{"name":"Institute of Pathology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying Vanessa","family":"Lim","sequence":"additional","affiliation":[{"name":"National Skin Center, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Shih Wee","family":"Khoo","sequence":"additional","affiliation":[{"name":"Dermatology Associates (Connexion), Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Siong See","family":"Lee","sequence":"additional","affiliation":[{"name":"National Skin Center, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"R1-20261015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.clindermatol.2020.06.010","article-title":"Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions","volume":"38","author":"Cheraghlou","year":"2020","journal-title":"Clin Dermatol"},{"key":"R2-20261015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/ACI.0b013e32832cda4c","article-title":"Fixed drug eruption: pathogenesis and diagnostic tests","volume":"9","author":"Shiohara","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-20261015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1440-0960.2001.00516.x","article-title":"Neutrophilic fixed drug eruption","volume":"42","author":"Agnew","year":"2001","journal-title":"Australas J Dermatol"},{"key":"R4-20261015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/ced.13740","article-title":"Neutrophilic fixed drug eruption: a mimic of neutrophilic dermatoses","volume":"44","author":"Suzuki","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"R5-20261015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/cup.14487","article-title":"Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature","volume":"50","author":"Theroux","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R6-20261015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00000372-198712000-00010","article-title":"Histological phases of Bactrim-induced fixed drug eruption. The report of one case","volume":"9","author":"Van Voorhees","year":"1987","journal-title":"Am J Dermatopathol"},{"key":"R7-20261015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaad.2005.01.095","article-title":"Neutrophilic fixed drug eruption caused by naproxen: a real entity or a stage in the histopathologic evolution of the disease?","volume":"53","author":"Ozkaya","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R8-20261015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18176\/jiaci.0687","article-title":"Neutrophilic generalized fixed drug eruption induced by etoricoxib","volume":"31","author":"Vera","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R9-20261015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/DAD.0000000000000157","article-title":"Neutrophilic fixed drug eruption","volume":"37","author":"Waldman","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R10-20261015","first-page":"1289","article-title":"Fixed drug eruptions - the common and novel culprits since 2000","volume":"20","author":"McClatchy","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"R11-20261015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0190-9622(87)70220-5","article-title":"Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline","volume":"17","author":"Shelley","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R12-20261015","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.2310\/6620.2011.10119","article-title":"Pseudoephedrine may cause \u201cpigmenting\u201d fixed drug eruption","volume":"22","author":"Ozkaya","year":"2011","journal-title":"Dermatitis"},{"key":"R13-20261015","doi-asserted-by":"crossref","first-page":"618897","DOI":"10.3389\/fimmu.2020.618897","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2020","journal-title":"Front Immunol"},{"key":"R14-20261015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2008.08516.x","article-title":"In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption","volume":"158","author":"Mizukawa","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:00:34Z","timestamp":1792072834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003454","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}